Reduced Dose Craniospinal Radiotherapy in Children With Medulloblastoma
Children's Oncology Group (COG)
Clinical Trial
Offered by: Nemours
Locations: Delaware Valley, Jacksonville, FL, Orlando, FL, Pensacola, FL
Trial Name
A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children With Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial.
What is the trial about?
To find out if the overall dose of radiation to the brain and spine can be reduced without decreasing rates of survival in children with medulloblastoma.
Who can participate?
> 3 and < 7 yrs of age.
What is involved?
Length of study is 14 months. Standard cancer care.
Contact Nemours Clinical Trials
Trial Name: A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children With Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial
COG#: ACNS0331
Contact Information
(800) 354-5690
ClinicalTrials@nemours.org